support@wellfortindia.com
support@wellfortindia.com
Empowering health with a range of life-saving solutions, from immunoglobulins to coagulation factors.
Explore our extensive array of meticulously crafted medical products, including immunoglobulins, vaccines, and coagulation factors, all designed to combat diseases and enhance patient well-being. At Wellfort India, our commitment to quality and innovation ensures that each product meets the highest standards of safety and efficacy, empowering healthcare professionals to provide the best possible care to their patients.
•Anti Rabies Vaccine (Vero cell)
•Human Rabies Immunoglobulin
•Hepatitis B Immunoglobulin
•Hepatitis B Immunoglobulin IV
•Anti D Immunoglobulin (Polyclonal)
•Human Normal Immunoglobulin
•Human Tetanus Immunoglobulin
•Human Albumin 20%
•Human Plasma Coagulation Factor VIII
•Human Plasma Coagulation Factor IX
The Anti Rabies Vaccine (Vero cell) epitomizes our commitment to leveraging innovative solutions in the fight against rabies, a deadly viral infection transmitted through the bite of infected animals. Developed utilizing advanced Vero cell technology, this vaccine represents a significant advancement in rabies prevention, offering robust protection against this relentless disease.
At Wellfort India, we prioritize safety and efficacy in the production of our Anti Rabies Vaccine. Our vaccine is manufactured using Vero cells, a well-established cell line known for its ability to produce high-quality vaccines with enhanced purity and potency. Through stringent quality control measures and meticulous manufacturing processes, we ensure that each dose of the vaccine meets the highest standards of safety and effectiveness.
The Anti Rabies Vaccine (Vero cell) works by stimulating the body’s immune response to produce antibodies against the rabies virus, providing proactive immunity against future exposure. Administered promptly following a suspected rabies exposure, this vaccine plays a crucial role in preventing the onset of rabies infection and potentially saving lives.
With its proven efficacy and safety profile, our Anti Rabies Vaccine (Vero cell) offers peace of mind to individuals at risk of rabies exposure, as well as to healthcare professionals administering the vaccine. By harnessing the power of cutting-edge technology and unwavering dedication to public health, Wellfort India continues to make significant strides in rabies prevention, contributing to a world free from the threat of this devastating disease.
Human Rabies Immunoglobulin, a critical component in rabies post-exposure prophylaxis, stands as a beacon of hope in the face of this deadly viral infection. Crafted with precision and care, our immunoglobulin formulation provides passive immunity against the rabies virus, offering crucial protection to individuals exposed to its wrath.
At Wellfort India, we understand the urgency and severity of rabies exposure, which is why our Human Rabies Immunoglobulin is meticulously manufactured to meet the highest standards of safety and efficacy. From sourcing the highest quality plasma to employing advanced purification techniques, every step of the production process is conducted with the utmost attention to detail and adherence to regulatory guidelines.
Our Human Rabies Immunoglobulin is designed to neutralize the rabies virus and prevent its spread within the body, effectively halting the progression of the disease. Administered promptly following exposure, it provides an essential shield against the potentially fatal consequences of rabies infection.
With Wellfort India’s Human Rabies Immunoglobulin, healthcare professionals can trust in a reliable and effective tool in their arsenal against rabies. Backed by rigorous quality assurance measures and a steadfast commitment to patient safety, our immunoglobulin offers peace of mind to both healthcare providers and patients alike in the fight against this formidable foe.
Hepatitis B Immunoglobulin stands as a vital defense against the threat of hepatitis B infection, a potentially serious liver disease caused by the hepatitis B virus. Wellfort India’s Hepatitis B Immunoglobulin is meticulously crafted to provide passive immunity, offering essential protection to individuals at risk of exposure to the virus.
Our Hepatitis B Immunoglobulin is formulated with precision, drawing upon the highest quality plasma and advanced purification techniques to ensure optimal safety and efficacy. Each batch undergoes rigorous testing and quality assurance protocols to meet stringent regulatory standards, providing healthcare professionals and patients with confidence in its reliability and effectiveness.
Administered promptly following exposure to the hepatitis B virus, our immunoglobulin works to neutralize the virus and prevent its replication within the body. This critical intervention reduces the risk of hepatitis B infection and its associated complications, offering peace of mind to individuals at risk and their healthcare providers.
At Wellfort India, we recognize the importance of proactive measures in combating hepatitis B infection. Our Hepatitis B Immunoglobulin serves as a cornerstone in hepatitis B prevention strategies, empowering healthcare professionals to safeguard their patients against this potentially life-threatening disease. With our unwavering commitment to quality and innovation, we continue to make strides in protecting global health against hepatitis B infection.
Hepatitis B Immunoglobulin IV represents a crucial advancement in the prevention and treatment of hepatitis B infection. Wellfort India’s Hepatitis B Immunoglobulin IV is specially formulated for intravenous administration, offering rapid and targeted protection against this potentially serious liver disease.
Crafted with precision and care, our Hepatitis B Immunoglobulin IV is derived from the highest quality plasma and undergoes meticulous purification processes to ensure purity and potency. Each batch is subjected to rigorous quality control measures to meet stringent regulatory standards, providing healthcare professionals and patients alike with confidence in its safety and efficacy.
The intravenous formulation of our immunoglobulin allows for rapid delivery directly into the bloodstream, maximizing its effectiveness in neutralizing the hepatitis B virus and preventing its replication. This swift intervention is particularly crucial in cases of acute exposure or in patients requiring immediate protection against hepatitis B infection.
Whether used for post-exposure prophylaxis or as part of a treatment regimen for hepatitis B, our Hepatitis B Immunoglobulin IV offers a reliable and effective means of combating this potentially life-threatening disease. With our unwavering commitment to innovation and patient care, Wellfort India continues to lead the way in advancing hepatitis B prevention and treatment strategies, ensuring a brighter and healthier future for all.
Anti D Immunoglobulin (Polyclonal) is a vital component in the prevention of hemolytic disease of the newborn (HDN), a condition that can result in severe complications for Rh-negative mothers and their Rh-positive babies. Wellfort India’s Anti D Immunoglobulin (Polyclonal) is carefully developed to provide passive immunity against RhD antigen, offering essential protection against the potentially devastating effects of Rh incompatibility during pregnancy.
Crafted with precision and care, our Anti D Immunoglobulin (Polyclonal) is derived from pooled human plasma, ensuring a diverse range of antibodies against the RhD antigen. Each batch undergoes rigorous purification processes to remove impurities and enhance safety and efficacy. Our commitment to quality is unwavering, with stringent quality control measures in place to meet regulatory standards and ensure the highest level of product integrity.
Administered prophylactically to Rh-negative mothers following potentially sensitizing events such as childbirth or miscarriage, our Anti D Immunoglobulin (Polyclonal) works by neutralizing Rh-positive fetal red blood cells circulating in the maternal bloodstream, preventing the development of maternal Rh sensitization and subsequent HDN in future pregnancies.
By providing passive immunity against RhD antigen, our Anti D Immunoglobulin (Polyclonal) offers peace of mind to expectant mothers and their healthcare providers, safeguarding the health and well-being of both mothers and babies. With our unwavering dedication to maternal and neonatal health, Wellfort India remains at the forefront of HDN prevention, striving to ensure positive outcomes for every pregnancy.
At Wellfort India, we prioritize safety and efficacy in the production of our Anti Rabies Vaccine. Our vaccine is manufactured using Vero cells, a well-established cell line known for its ability to produce high-quality vaccines with enhanced purity and potency. Through stringent quality control measures and meticulous manufacturing processes, we ensure that each dose of the vaccine meets the highest standards of safety and effectiveness.
The Anti Rabies Vaccine (Vero cell) works by stimulating the body’s immune response to produce antibodies against the rabies virus, providing proactive immunity against future exposure. Administered promptly following a suspected rabies exposure, this vaccine plays a crucial role in preventing the onset of rabies infection and potentially saving lives.
With its proven efficacy and safety profile, our Anti Rabies Vaccine (Vero cell) offers peace of mind to individuals at risk of rabies exposure, as well as to healthcare professionals administering the vaccine. By harnessing the power of cutting-edge technology and unwavering dedication to public health, Wellfort India continues to make significant strides in rabies prevention, contributing to a world free from the threat of this devastating disease.
Human Normal Immunoglobulin is a versatile therapeutic agent that plays a pivotal role in bolstering the body’s immune system and combating a wide range of infectious diseases. Wellfort India’s Human Normal Immunoglobulin is meticulously crafted to harness the power of natural antibodies, offering a potent defense against pathogens and providing essential support for individuals with compromised immune systems.
Crafted with precision and care, our Human Normal Immunoglobulin is derived from pooled human plasma, ensuring a diverse array of antibodies against a multitude of infectious agents. Through advanced purification processes and stringent quality control measures, we ensure the highest standards of safety, efficacy, and purity, providing healthcare professionals and patients alike with confidence in its reliability and effectiveness.
The versatility of Human Normal Immunoglobulin extends across various medical conditions, including primary and secondary immunodeficiencies, autoimmune disorders, and certain infectious diseases. Whether used as replacement therapy for immunodeficient patients or as adjunctive therapy for autoimmune conditions, our immunoglobulin offers a multifaceted approach to immune support and disease management.
Administered intravenously or subcutaneously, our Human Normal Immunoglobulin provides passive immunity, supplementing the body’s natural defenses and enhancing overall immune function. Its broad spectrum of action makes it an invaluable tool in the prevention and treatment of a myriad of diseases, contributing to improved health outcomes and enhanced quality of life for patients.
At Wellfort India, we remain committed to advancing healthcare through innovation and excellence. With our Human Normal Immunoglobulin, we empower healthcare professionals to provide optimal care for patients, harnessing the power of the immune system to promote health and well-being for all.
Human Tetanus Immunoglobulin stands as a vital shield against the relentless threat of tetanus, a potentially fatal bacterial infection characterized by painful muscle contractions. Crafted with precision and care, Wellfort India’s Human Tetanus Immunoglobulin offers passive immunity against the toxins produced by the tetanus bacteria, providing essential protection for individuals at risk of infection.
Derived from pooled human plasma and subjected to rigorous purification processes, our Human Tetanus Immunoglobulin ensures optimal safety and efficacy. Each batch undergoes meticulous testing and quality control measures to meet stringent regulatory standards, instilling confidence in healthcare professionals and patients alike.
Administered promptly following a tetanus-prone injury or as part of tetanus post-exposure prophylaxis, our immunoglobulin works swiftly to neutralize the tetanus toxin, preventing its harmful effects and halting the progression of the disease. This timely intervention is crucial in preventing the development of tetanus infection and mitigating its potentially severe complications.
With its proven track record of safety and effectiveness, our Human Tetanus Immunoglobulin offers peace of mind to individuals at risk of tetanus exposure, as well as to healthcare providers administering the vaccine. By providing passive immunity against tetanus toxins, we empower individuals to protect themselves against this formidable foe and ensure better health outcomes for all.
Human Albumin 20% serves as a vital therapy for patients requiring plasma volume expansion and oncotic pressure maintenance. Wellfort India’s Human Albumin 20% is meticulously formulated to replenish depleted albumin levels, restoring essential plasma proteins and promoting stability in critically ill patients.
Crafted with precision and care, our Human Albumin 20% is derived from high-quality human plasma and undergoes stringent purification processes to ensure purity and safety. Each batch is rigorously tested and meets strict regulatory standards, providing healthcare professionals with confidence in its reliability and efficacy.
Administered intravenously, our Human Albumin 20% acts as a colloidal osmotic agent, drawing fluid into the bloodstream and expanding plasma volume. This expansion helps to improve circulation, stabilize blood pressure, and restore oncotic pressure, thereby supporting vital organ function and promoting optimal tissue perfusion.
Indicated for a variety of clinical scenarios, including hypovolemia, hypoalbuminemia, and certain forms of shock, our Human Albumin 20% offers a versatile therapeutic option for patients in need of fluid resuscitation and volume support. Its ability to restore essential plasma proteins makes it an invaluable tool in the management of critically ill patients across diverse medical specialties.
At Wellfort India, we remain dedicated to advancing healthcare through innovation and excellence. With our Human Albumin 20%, we empower healthcare professionals to provide optimal care for patients, restoring balance and stability for improved health outcomes.
Human Plasma Coagulation Factor VIII stands as a lifeline for individuals living with hemophilia A, a hereditary bleeding disorder characterized by deficient or defective clotting factor VIII. Crafted with precision and care, Wellfort India’s Human Plasma Coagulation Factor VIII offers essential support for hemostasis, enabling patients to lead fuller, more active lives.
Derived from high-quality human plasma and subjected to rigorous purification processes, our Factor VIII concentrate ensures purity, potency, and safety. Each batch undergoes extensive testing and meets stringent regulatory standards, providing healthcare professionals and patients with confidence in its reliability and efficacy.
Administered intravenously, Human Plasma Coagulation Factor VIII acts as a critical replacement therapy for patients with hemophilia A, restoring deficient clotting factor levels and promoting effective blood coagulation. This intervention helps to prevent and control bleeding episodes, reducing the risk of complications and improving overall quality of life for patients.
Indicated for both prophylactic and on-demand treatment, our Factor VIII concentrate offers flexibility and versatility in the management of hemophilia A. Whether used to prevent bleeding during daily activities or to address acute bleeding episodes, it serves as a cornerstone in hemophilia care, empowering patients to live without the fear of spontaneous bleeds.
At Wellfort India, we are committed to enhancing the lives of individuals with hemophilia A through innovation and excellence. With our Human Plasma Coagulation Factor VIII, we provide patients and healthcare professionals with a reliable and effective treatment option, enabling better management of this challenging bleeding disorder.
Human Plasma Coagulation Factor IX stands as a crucial therapeutic intervention for individuals battling hemophilia B, a rare bleeding disorder characterized by deficiency or dysfunction of clotting factor IX. Crafted with precision and care, Wellfort India’s Human Plasma Coagulation Factor IX offers essential support for hemostasis, empowering patients to lead active and fulfilling lives.
Derived from high-quality human plasma and subjected to stringent purification processes, our Factor IX concentrate ensures purity, potency, and safety. Each batch undergoes rigorous testing and meets stringent regulatory standards, providing healthcare professionals and patients alike with confidence in its reliability and efficacy.
Administered intravenously, Human Plasma Coagulation Factor IX acts as a vital replacement therapy for patients with hemophilia B, restoring deficient clotting factor levels and promoting effective blood coagulation. By replenishing Factor IX activity, it helps to prevent and control bleeding episodes, reducing the risk of complications and improving overall quality of life for patients.
Indicated for both prophylactic and on-demand treatment, our Factor IX concentrate offers flexibility and versatility in the management of hemophilia B. Whether used to prevent bleeding during daily activities or to address acute bleeding episodes, it serves as a cornerstone in hemophilia care, empowering patients to live without the fear of spontaneous bleeds.
At Wellfort India, we are committed to advancing hemophilia care through innovation and excellence. With our Human Plasma Coagulation Factor IX, we provide patients and healthcare professionals with a reliable and effective treatment option, enabling better management of this challenging bleeding disorder.